Analystreport

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target lowered by analysts at Wedbush from $26.00 to $20.00.

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report